Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omics-based coenzyme Q10 strategy in Parkinson’s disease
DRKS00015880Phase 2Not yet recruiting
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing QuinoMit Q10 fluid with Placebo (2 arms). Planned start Nov 2018; status: not yet recruiting.
02
Drugs
ubiquinol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on DRKS00015880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015880.